According to the Zhitong Finance App, Baixin International (00574) announced annual results for the year ended December 31, 2023. The group obtained revenue of RMB 129 million (same unit), an increase of 80.3% over the previous year; profit attributable to the company's shareholders was 2.35 million yuan, compared with a loss of 43.379 million yuan in the same period last year; profit per share was 0.16 points.

According to the announcement, the increase in revenue was mainly due to the gradual improvement of the economy and overall market climate as the novel coronavirus (COVID-19) epidemic was brought under control in early 2023; and the Group obtained distribution rights for 10 new pharmaceutical products for the year ended December 31, 2023.